Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenues
Revenues from external customers	$ 23,583	$ 18,299	$ 83,845	$ 73,720
Operating Expenses
Impairment of goodwill		178	9,635	178
Impairment of other noncurrent assets			13,326	448
Other Expense, Net
Unrealized and realized appreciation (depreciation) in fair value of equity securities and preferred stock, net			(106)	2,634
Equity in net loss of affiliates			(1,163)	(5,034)
Loss from continuing operations before income taxes	(29,558)	(49,057)	(102,934)	(134,284)
Loss from discontinued operations, net of income taxes	0	(4,580)	(26,056)	(20,442)
Net loss	(29,508)	(53,634)	(128,860)	(154,701)
Net loss attributable to the noncontrolling interests	0	0	0	1,592
Net loss attributable to Precigen	(29,508)	(53,634)	(128,860)	(153,109)
Amounts Attributable to Precigen
Net loss from continuing operations attributable to Precigen	(29,508)	(49,054)	(102,804)	(132,667)
Net loss from discontinued operations attributable to Precigen	0	(4,580)	(26,056)	(20,442)
Net loss attributable to Precigen	$ (29,508)	$ (53,634)	$ (128,860)	$ (153,109)
Net Loss per Share
Net loss from continuing operations attributable to Precigen per share, basic and diluted (in dollars per share)	$ (0.18)	$ (0.32)	$ (0.63)	$ (0.86)
Net loss from discontinued operations attributable to Precigen per share, basic and diluted (in dollars per share)	0	(0.03)	(0.16)	(0.14)
Net loss attributable to Precigen per share, basic and diluted (in dollars per share)	$ (0.18)	$ (0.35)	$ (0.79)	$ (1.00)
Weighted average shares outstanding, basic and diluted (in shares)	165,527,024	154,596,257	163,318,375	153,770,785
Collaboration and licensing agreements
Revenues
Revenues from external customers	$ 5,223	$ 2,296	$ 20,259	$ 14,717
Continuing Operations
Revenues
Revenues from external customers	23,583	18,299	83,845	73,720
Operating Expenses
Research and development	12,154	25,667	45,253	80,844
Selling, general and administrative	22,300	22,187	64,057	72,486
Impairment of goodwill	0	178	9,635	178
Impairment of other noncurrent assets	920	448	13,326	448
Operating expenses	48,561	62,936	173,994	199,946
Operating loss	(24,978)	(44,637)	(90,149)	(126,226)
Other Expense, Net
Unrealized and realized appreciation (depreciation) in fair value of equity securities and preferred stock, net	0	(3,139)	0	3,070
Interest expense	(4,646)	(4,466)	(13,830)	(13,124)
Interest and dividend income	579	883	2,025	3,268
Other income, net	10	2,781	145	671
Total other expense, net	(4,057)	(3,941)	(11,660)	(6,115)
Equity in net loss of affiliates	(523)	(479)	(1,125)	(1,943)
Loss from continuing operations before income taxes	(29,558)	(49,057)	(102,934)	(134,284)
Income tax benefit	50	3	130	25
Loss from continuing operations	(29,508)	(49,054)	(102,804)	(134,259)
Continuing Operations | Collaboration and licensing agreements
Revenues
Revenues from external customers	5,223	2,296	20,259	14,717
Continuing Operations | Products
Revenues
Revenues from external customers	6,896	5,846	20,397	18,483
Operating Expenses
Cost of products and services	7,296	7,906	21,526	24,130
Continuing Operations | Services
Revenues
Revenues from external customers	11,288	9,924	42,615	39,707
Operating Expenses
Cost of products and services	5,891	6,550	20,197	21,860
Continuing Operations | Other
Revenues
Revenues from external customers	$ 176	$ 233	$ 574	$ 813